AFP and liver cancer: Serum alpha-fetoprotein (AFP) assay is a traditional useful method for diagnosis and monitoring of HCC, but the application of AFP for liver cancer is unsatisfactory, and it is not sufficient to predict the prognosis for HCC patients effectively (8).